<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04364906</url>
  </required_header>
  <id_info>
    <org_study_id>QL20011990</org_study_id>
    <nct_id>NCT04364906</nct_id>
  </id_info>
  <brief_title>Comparison of the Effects of QLB 2 and QLB 3 on Post-operative Analgesia in Cesarean Section Surgery</brief_title>
  <official_title>Comparison of the Effects of Quadratus Lumborum Block 2 and 3 (QLB 2 and QLB 3) on Post-operative Analgesia in Cesarean Section Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ondokuz Mayıs University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ondokuz Mayıs University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the post-operative analgesic effects of quadratus lomborum block 2 and 3
      (QLB 2, 3) in patients having cesarean section with spinal anesthesia. Spinal anesthesia will
      be performed to all patients for the surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, patients are divided into two groups. After the spinal anesthesia is performed
      and cesarean section surgery is over; QLB 2 block will be performed to patients in Group A ;
      while QLB 3 block will be performed to patients in Group B.

      In addition, patient controlled analgesia (PCA) will be used in the first 24 hours
      postoperatively.

      Group A - Patients in group A will have QLB 2 block after the surgery. In addition, patient
      controlled analgesia (PCA) will be used in the first 24 hours postoperatively.

      Group B - Patients in group B will have QLB 3 block after the surgery. In addition, patient
      controlled analgesia (PCA) will be used in the first 24 hours postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomization of the study will be done by a doctor who will not participate in patient follow-up with closed envelopes using computer generated randomization codes.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The anesthesia doctor who will perform the interfascial plane block (QLB 2, 3) will be informed with a sealed envelope by an independent assistant outside the study, and the patient will not know which block is performed.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative acute pain</measure>
    <time_frame>1 day</time_frame>
    <description>Pain status will be evaluated based on NRS scores. Pain status will be evaluated at 1, 3, 6, 9, 12, 18, 24. hours after surgery. Each NRS is scores 0-10. (0=no pain ; 10=pain as bad as can be)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid consumption in the first 24 hours after surgery</measure>
    <time_frame>1 day</time_frame>
    <description>Morphine consumption in the first 24 hours will be counted by IV patient controlled analgesia device (PCA). Patients will be able to request opioids via PCA device when the nrs score is above 4.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Analgesia</condition>
  <condition>Acute Pain</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Quadratus Lumborum Block 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Quadratus Lumborum Block 2 (QLB 2) will be performed the patients in Group A after the cesarean section surgery. Patient controlled analgesia device (PCA) is used for all the patients in the first 24 hours postoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quadratus Lumborum Block 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Quadratus Lumborum Block 3 (QLB 3) will be performed the patients in Group B after the cesarean section surgery. Patient controlled analgesia device (PCA) is used for all the patients in the first 24 hours postoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regional anesthesia</intervention_name>
    <description>The effects of QLB 2, 3 interfascial plane blocks on post-operative analgesia after cesarean section surgery</description>
    <arm_group_label>Quadratus Lumborum Block 2</arm_group_label>
    <arm_group_label>Quadratus Lumborum Block 3</arm_group_label>
    <other_name>Quadratus Lumborum Block 2</other_name>
    <other_name>Quadratus Lumborum Block 3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being pregnant for at least 37 weeks

          -  Planning an elective cesarean operation

          -  Being between the ages of 18-45

        Exclusion Criteria:

          -  ASA 3-4 patients with comorbitidies (Serious renal, cardiac, hepatic disease)

          -  Being operated with general anesthesia

          -  Obesity (&gt; 100 kg, BMI&gt; 35 kg / m2)

          -  Contraindication of regional anesthesia (quagulopathy, abnormal INR, thrombocytopenia,
             infection at the injection site)

          -  Hypersensitivity to local anesthetics or a history of allergy

          -  Patients with a history of opioid use longer than four weeks

          -  Patients with psychiatric disorders

          -  Patients with anatomic deformity

          -  Patients who do not want to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women planned for elective cesarean operation</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ERSİN KÖKSAL, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ondokuz Mayıs University Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CANER GENÇ, MD</last_name>
    <phone>05444846865</phone>
    <phone_ext>+9</phone_ext>
    <email>caner.genc@omu.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>GÖKÇE ŞENOCAK, MD</last_name>
    <phone>05449771624</phone>
    <phone_ext>+9</phone_ext>
    <email>ngokcesenocak@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ondokuz Mayıs University Faculty of Medicine</name>
      <address>
        <city>Samsun</city>
        <state>Other</state>
        <zip>55200</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CANER GENÇ</last_name>
      <phone>05444846865</phone>
      <email>caner.genc@omu.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 23, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ondokuz Mayıs University</investigator_affiliation>
    <investigator_full_name>Caner Genç</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Acute and chronical pain</keyword>
  <keyword>Quadratus Lumborum Blocks</keyword>
  <keyword>Cesarean Section</keyword>
  <keyword>Spinal Anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

